CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares trading hands.
CardioGenics Stock Performance
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Stories
- Five stocks we like better than CardioGenics
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These Quality Dividend Kings Grow their Dividends the Fastest
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Growth Stocks to Buy in September
- Compound Interest and Why It Matters When Investing
- 3 Underappreciated Stocks with Nowhere to Go But Up
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
